These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of the stability of (99m)Tc-ECD and stabilized (99m)Tc-HMPAO stored in syringes. Koslowsky IL; Brake SE; Bitner SJ J Nucl Med Technol; 2001 Dec; 29(4):197-200. PubMed ID: 11756532 [TBL] [Abstract][Full Text] [Related]
3. Sensitivity of technetium-99m-d,1-HMPAO to radiolysis in aqueous solutions. Tubergen K; Corlija M; Volkert WA; Holmes RA J Nucl Med; 1991 Jan; 32(1):111-5. PubMed ID: 1988613 [TBL] [Abstract][Full Text] [Related]
4. Radiochemical purity of technetium-99m-HMPAO depends on specific activity. Piera C; Martínez A; Ramírez I J Nucl Med; 1995 Apr; 36(4):706. PubMed ID: 7699470 [No Abstract] [Full Text] [Related]
5. Morphological and functional status of leukocytes labelled with 99m technetium HMPAO. De Labriolle-Vaylet C; Linhart NC; Petiet A; Bok B Prog Clin Biol Res; 1990; 355():119-29. PubMed ID: 2177895 [No Abstract] [Full Text] [Related]
6. Effect of source and age of sodium pertechnetate Tc 99m on radiochemical purity of technetium Tc 99m exametazime. Millar AM Am J Hosp Pharm; 1993 Jan; 50(1):103-6. PubMed ID: 8381258 [TBL] [Abstract][Full Text] [Related]
7. HMPAO--fundamental and clinical research. Symposium of the Rheinisch-Westfäliche Gesellschaft für Nuklearmedizin. Bonn, 1987. Abstracts. Nuklearmedizin; 1988 Jun; 27(3):108-17. PubMed ID: 3405778 [No Abstract] [Full Text] [Related]
8. Tc-99m-HMPAO as a lymphocyte label. Schmidt KG; Poulsen BS; Rasmussen JW; Johansen J; Rønne M Prog Clin Biol Res; 1990; 355():209-18. PubMed ID: 2281101 [No Abstract] [Full Text] [Related]
9. Determination of brain death with technetium-99m-HMPAO. Brandau W; Schober O; Knapp WH J Nucl Med; 1990 Dec; 31(12):2075-6. PubMed ID: 2266412 [No Abstract] [Full Text] [Related]
14. In vivo quality control of technetium-99m-HMPAO. Grünwald F; Biersack HJ J Nucl Med; 1991 Jun; 32(6):1316-7. PubMed ID: 2045956 [No Abstract] [Full Text] [Related]
15. A method for stabilising technetium-99m exametazime prepared from a commercial kit. Weisner PS; Bower GR; Dollimore LA; Forster AM; Higley B; Storey AE Eur J Nucl Med; 1993 Aug; 20(8):661-6. PubMed ID: 8404951 [TBL] [Abstract][Full Text] [Related]
16. Marked lung uptake of Tc-99m HMPAO in a polysubstance-abusing marijuana and tobacco smoker. Shih WJ; Carmona JJ; Coupal JJ; Lee JK Clin Nucl Med; 1996 Feb; 21(2):156. PubMed ID: 8697694 [No Abstract] [Full Text] [Related]
17. A reconstitution protocol for Ceretec. Hewat CD Nucl Med Commun; 1992 Feb; 13(2):121-2. PubMed ID: 1436898 [No Abstract] [Full Text] [Related]
18. On the synthesis, isolation, and radiochemical studies for the preparation of in-house kits for 99mTc-meso- and d,l-HMPAO: a few additional observations. Banerjee S; Samuel G; Kothari K; Sarma HD; Pillai MR Nucl Med Biol; 1999 Apr; 26(3):327-38. PubMed ID: 10363805 [No Abstract] [Full Text] [Related]
19. Technetium-99m labelling of bis-oxime ligands. Jackson GE; Byrne MJ; Fakier H; Hunter R; Woudenberg M Appl Radiat Isot; 1994 May; 45(5):581-6. PubMed ID: 8019521 [TBL] [Abstract][Full Text] [Related]
20. Quantitative study of the structure-stability relationship of TcvO(III) complexes. Kung HF; Liu BL; Wei Y; Pan S Int J Rad Appl Instrum A; 1990; 41(8):773-81. PubMed ID: 2172189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]